PharmaDossierIndependent biopharma information, guidance, and source-cited analysis.

PHARMApharmadossier

Topic

Methotrexate

Universal first-line csDMARD anchor, NADAC price floor, Orange Book ANDA availability, and step-therapy gatekeeping.

1 article·Lives underGenerics Pricing & Access·Last updated 2026-08-10

Specialty· August 10, 2026 · 16 min read

Rheumatoid Arthritis Treatment Access (2026): Methotrexate, Biosimilars, and JAKs

By Ran Chen#Rheumatoid Arthritis #Specialty Pharmacy #Payer Policy